During your opponent's next turn, any damage done to Lucario by attacks is reduced by 20 (after applying Weakness and Resistance).
This attack's damage isn't affected by Resistance, Poké-Powers, Poké-Bodies, or any other effects on the Defending Pokémon
POP Series 8 was released in 2008. POP Series 8 is grouped under the POP era.
The checklist contains 17 cards, placing it in a compact expansion range. As of 2026, the set is 18 years old and fits a legacy-era profile.
Within this set, Lucario is card number 2 with a Rare designation.
Lucario is a POP Series 8 card from the 2008 release window. Card flavor text reads: "By catching the aura emanating from others, it can read their thoughts and movements." Its card type is Pokémon.
The rarity label is Rare. Printed HP is 90.
Energy typing is Fighting. This gives collectors a clear identity footprint for the print.
This card evolves from Riolu. Notable move text references "Blocking Punch" and "Striking Kick".
Current market pricing for Lucario (POP Series 8) sits near $18.08. Its 7-day movement is largely flat at 0.0%.
It now sits 2.0% above its 30-day average of $17.72. Its 90-day trading band runs between $9.53 and $18.49, producing a 50% range and moderate-volatility behavior.
The listed rarity for this print is Rare.
Collectors tracking Lucario often benchmark it against other Lucario cards. This comparison sample includes 6 alternatives across 5 sets.
Comparable prices currently cover $0.26-$5.27, a 1927% band. Against the sample mean of $2.05, this card is +782%.
Notable alternatives include Lucario #XY140 (XY Black Star Promos) at $5.27, Lucario #63 (Fates Collide) at $1.38, Lucario #47 (Fates Collide) at $0.49, and Lucario #SWSH186 (SWSH Black Star Promos) at $4.55.
Collector-focused market read: We observe a 0.0% shift this week, which points toward price consolidation rather than immediate volatility. With a 50% 90-day spread ($9.53-$18.49), this card currently tracks as moderate-volatility.
Current value remains close to its 30-day mean ($17.72). Graded comparison currently centers on PSA 9 near $92.26, representing +410% over raw value.
